|
P3-152 O-T03F-3182
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Artificial antigen presenting cell elasticity modulates CD8+ T cell activation, macrophage uptake, and protein corona
Jordan Green
|
|
P3-153 O-T03D-3788
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Immune engineered extracellular vesicles to modulate T cell activation in type 1 diabetes
Edward Phelps
|
|
P3-154 E-T03F-2207
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Inflammation-controlled anti-inflammatory hydrogels
Manfred Maitz
|
|
P3-155 P-T03C-0564
Biomaterials for theranostics
-
Drug delivery
A cooling agent delivery hydrogel for adipocyte browning in the treatment of obesity and obesity-related diabetes
Yu-Jung Lin
|
|
P3-156 O-T03F-3396
Biomaterials for theranostics
-
Immunomodulatory biomaterials
IL-10 and BMP-7 enhance the osteoconductivity of collagen-hydroxyapatite scaffolds through immunomodulation of the blood-biomaterial interaction
William Lackington
|
|
P3-157 P-T03C-4043
Biomaterials for theranostics
-
Drug delivery
Whey protein isolate-based microspheres and films used in controlled release
Justyna Kozlowska
|
|
P3-158 O-T03F-0455
Biomaterials for theranostics
-
Immunomodulatory biomaterials
In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity
Michael Mitchell
|
|
P3-159 O-T03D-2611
Biomaterials for theranostics
-
Exosome and extracellular vesicle
CRISPR-based in vivo gene therapy for osteoarthritis: utilizing slow-release hybrid exosomes for chondrocyte-targeted FOXO3 gene-editing to activate mitochondrial autophagy
Qiguang Wang
|
|
P3-160 E-T03F-2701
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Biomimetic Mineralization Materials for Cell Function Regulation in Cancer Therapy
Ruibo Zhao
|
|
P3-161 O-T03F-2234
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Bioinspired glycopeptide hydrogel as immunomodulatory niche for tissue repair
Weiwei Wang
|
|
P3-162 P-T03F-2747
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Evaluation of proinflammatory response to polymeric materials using a genetically-modified macrophage cell line with luminescent peptide
Tsuyoshi Kimura
|
|
P3-163 O-T03F-1202
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Exposure to hydroxyapatite nanoparticles enhances the responsiveness of immune cells to TLR agonist and promotes TLR agonist-mediated anti-tumor immunity
Qin Zeng
|
|
P3-164 O-T03F-0154
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Immunomodulatory effect of SCPC bioactive ceramic promotes wound healing and muscle tissue regeneration
Ahmed El-Ghannam
|
|
P3-165 E-T03F-1716
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Response of Lymphocytes to Biomaterial Treated Skeletal Muscle Injury
Daphna Fertil
|
|
P3-167 E-T03F-1475
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Understanding biomaterial effects on macrophage-based cell therapies for volumetric muscle loss
Samuel Sung
|
|
P3-168 O-T03F-0709
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Polymeric mRNA Nanoparticles Reprogram Dendritic Cells and Induce Immune Tolerance
Sarah Neshat
|
|
P3-169 O-T03D-1009
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Pancreatic Tumor-Derived Extracellular Vesicles Stimulate Schwann Cell Activation and Perineural Invasion via IL-8 Signaling
Emory Gregory
|
|
P3-170 E-T03D-0752
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Hydrogel interference with extracellular vesicle quantification methods – implications for assessing EV release from hydrogels
Hannah Aris
|
|
P3-171 E-T03F-1108
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Coiled-coil peptide nanofibers as a platform for a dual-target active immunotherapy against complement anaphylatoxins.
Helena Freire Haddad
|
|
P3-172 P-T03D-3922
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Endogenous Antiviral Properties of Red Blood Cell-Derived Extracellular Vesicles and Their Augmentation of Antiviral Oligonucleotide Therapy
Chang Gao
|
|
P3-173 O-T03D-0772
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Molecular tuned extracellular blebs for improved vaccination and intracellular delivery
Olivia Ritchie
|
|
P3-174 O-T03E-0770
Biomaterials for theranostics
-
Gene therapy
Multimodal gene therapy for cancer in combination of targeted therapeutics
Rebecca Lee
|
|
P3-175 P-T03C-1296
Biomaterials for theranostics
-
Drug delivery
Cellular delivery of mRNA using hyaluronic acid-coated polymeric micelles
Yuichi Kuwano
|
|
P3-176 P-T03D-1518
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Role of extracellular vesicles in advanced negative pressure wound therapy
Lin Yu-Chen
|
|
P3-177 O-T03F-0383
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Conjugation of IL-33 to microporous annealed particle scaffolds enhances the type 2 immune response
Colleen Roosa
|
|
P3-178 E-T03D-1438
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Injectable microgels with hybrid exosomes of chondrocyte-targeting FGF18 gene-editing and self-renewable lubrication synergistically mitigate osteoarthritis progression
Manyu Chen
|
|
P3-179 E-T03F-0971
Biomaterials for theranostics
-
Immunomodulatory biomaterials
Immunoregulatory hybrid microchannels reinforce endogenous bone regeneration by regulating the CSF-1/CSF-1R pathway of macrophages
Xing Li
|
|
P3-180 P-T03E-2559
Biomaterials for theranostics
-
Gene therapy
Microfluidic-based gene delivery to T cells and applications on triple-negative breast cancer therapy
Yi-Hsuan Tung
|
|
P3-181 P-T03D-1867
Biomaterials for theranostics
-
Exosome and extracellular vesicle
Profiling heart-specific exosomes to enable research of cardiovascular disease
Rosie Kao
|
|
P3-182 P-T03C-0175
Biomaterials for theranostics
-
Drug delivery
Design of cell nuclear nanotransporters by importin mimicry and application in nuclear-targeting DDS
Soma Kawashima
|
Login
